Please login to the form below

Not currently logged in
Email:
Password:

Bristol Myers-Squibb

This page shows the latest Bristol Myers-Squibb news and features for those working in and with pharma, biotech and healthcare.

Janssen looks to expand Darzalex in Europe

Janssen looks to expand Darzalex in Europe

Additionally, both MorphoSys and Takeda each have their own myeloma drugs in mid-stage testing and Bristol-Myers Squibb and AbbVie are hoping that SLAMF7 targeting Empliciti, in combination with Revlimid,

Latest news

More from news
Approximately 128 fully matching, plus 834 partially matching documents found.

Latest Intelligence

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    The cells were gene-edited to lack PD-1, the immune checkpoint targeted by drugs such as Merck &Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab), and the

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    oral therapies such as Tyk inhibitors from Bristol-Myers Squibb and others, but outcomes data could help AbbVie persuade prescribers to plump for its drug, assuming it gets regulatory approvals.

  • Is China ready for a pharmaceutical gold rush?

    Bristol-Myers Squibb’s (BMS)’s Opdivo (nivolumab) was approved for the treatment of non-small cell lung cancer (NSCLC) in June.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    Pangalos swiftly recruited oncologist Susan Galbraith, then working at Bristol- Myers Squibb, to head AstraZeneca’s IMED oncology team, which focused on small molecule drug development in oncology.

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Checkpoint inhibitors – old and new. The first wave of checkpoint inhibitors targeting PD-(L) 1 and CTLA-4, from Bristol-Myers Squibb, Merck &Co, Roche, AstraZeneca and Merck KGaA/Pfizer, have

More from intelligence
Approximately 4 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 10 fully matching, plus 100 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics